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BNCT (boron neutron capture therapy) is a binary radiation therapy for the treatment of cancer, based on the capture of thermal neutrons by 10B nuclei that have been selectively delivered to tumour cells. The neutron capture event results in the formation of excited 11B nuclei that undergo fission to yield highly energetic 4He2+ and 7Li3+ ions. Cell death is triggered by the release of these charged particles which create ionisation tracks along their trajectories, resulting in cellular damage. It has been estimated that approximately 10−30 µg of boron per gram of tumour mass is needed to attain an acceptable therapeutic advantage.[1] An important task relies on the possibility of delivery high payloads of 10B at the target sites and polynuclear boron derivatives are potential candidates for BNCT applications. Several functionalised carboranes have been employed to construct boron delivery vehicles for BNCT, because of their high content of boron and their stability in vivo. In recent years our research group has been working on the preparation of dual agents for BNCT/MRI applications. In these systems a carborane cage is linked to a lipophilic unit, in order to exploit LDLs as biological vectors, and a MRI probe.[2] In vivo MR image acquisition showed that the amount of B taken up in the tumour region was above the threshold for successful NCT treatment.[3] With the goal of improving the efficacy as theranostic agents (therapy + diagnostic) several new compounds have been prepared and tested. Firstly the biological vector as been chaged by the introduction of a cholesterol unit using liposomes as carriers, secondly by exploiting the Huisgen reaction to link both the MRI probe and the lipophilic unit by a triazole ring. Both these systems were tested 

